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Objectives: The diffusion of cost-utility analyses (CUAs) through the medical literature
was examined, documenting visible patterns and determining how they correspond with
expectations about the diffusion of process innovations.
Methods: This study used 539 CUAs from a registry. It includes data elements
comprising year of publication, the research center in which the study was performed, the
clinical area covered by the CUA, and the specific journal. Finally, each paper was
assigned to a journal type that could be one of the three categories: health services
research, general medicine, or clinical specialty.
Results: When the average number of publications is plotted against time, the plot reveals
an S-shaped curve. It appears that, whereas CUAs initially were published more frequently
in general medical or health services research journals, there was a clear increase in the
diffusion of CUA into subspecialty journals over time. The concentration ratio for research
centers as measured by the Herfindhal–Hirschman Index decreased over time.
Conclusions: The spread of CUA through the medical literature follows patterns
identified for the diffusion of other new technologies and processes. Future research
should focus on what impact this spread has had on the practice of medicine and
formulation of health policy.
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Over the past 25 years, rising medical cost has been a com-
mon concern of policy-makers as well as researchers. In
the 1970s, methodology intended to assess both the cost
and benefits gained from health-care expenditures entered
the medical literature. For simplicity, we refer to those
cost-effectiveness analyses using quality-adjusted life years
(QALYs) as an outcome measure as cost-utility analyses
(CUAs).
Cost-utility analysis is a methodological approach to as-
sessing the value of a given health technology, program, or
intervention. As such, it can be considered a process inno-
vation, one of many designed to improve the ability to make
informed decisions about utilization and coverage of medi-
cal interventions. One concern about CUAs is that they have
not been broadly used by decision-makers in health care.
This finding may be because CUAs have been performed
by researchers and may not be broadly accessible to or in-
terpretable by policy-makers (4;5;11). Medical practitioners
and policy-makers may be unsure about the correctness of
the analyses or its real-life implications for the medical-care
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system (7;8). In addition, the analyses may not be useful be-
cause the end goals are constrained by pressures other than
simple economic efficiency.
The use of an innovation also depends on the stage of
innovation. Typologies for the stage of innovation have been
described previously. Generally, innovation begins with re-
alization of the need for innovation. A second stage enacts
ideas for the specific form of the innovation. In the third
stage, the innovation is first brought into practical use. A
final stage includes the routine use of the innovation (9).
The recommendation of the Panel on Cost-Effectiveness
Analysis in Health and Medicine led to the enactment of
a plan for a specific form of cost-utility analysis (referred
to as a “reference case”) so that analyses would be com-
parable across different medical practices and disease types
(3). Since that time, some organizations have begun to use
CUA more broadly in decision making (2;10). In addition to
implementation, innovation faces the question of diffusion
or dissemination. Potential users of an innovation need to
become aware of the innovation and then make a decision
about whether or not to adopt it. Individuals and organiza-
tions can be considered along an adoption continuum starting
with the innovators and progressing from early adopters to
those who wait until the technology is well-developed and
understood (1;9). Successful implementation in one setting
does not necessarily ensure broad dissemination of an inno-
vation. Our specific interest in this article was to examine the
diffusion of CUAs through the medical literature to deter-
mine what patterns can be seen and how they correspond
with general expectations about the diffusion of process
innovations.
METHODS
A systematic review of the English-language medical
literature from 1976 through 2001 identified 539 CUAs
that met inclusion criteria for this study published
in MEDLINE-indexed journals (http://www.hsph. har-
vard.edu/cearegistry/refs.html). Each article was read inde-
pendently by two readers using a standardized data form, with
consensus meetings to resolve discrepancies. For this study,
we included data elements encompassing year of publica-
tion, the research center in which the study was performed,
the clinical area covered by the CUA, and the specific journal.
Finally, we assigned each paper to a journal type that could
be one of the three categories: health services research (e.g.
Journal of Health Services Research), general medicine (e.g.
JAMA, Annals of Internal Medicine), or clinical specialty
(e.g. Radiology, Journal of Clinical Oncology).
We used the HHI to measure dispersion and share of
CUAs performed in various centers. HHI is calculated by
squaring the market share (percentage) of each firm (institu-
tion) “competing” in the market (of CUAs) and then summing
the resulting numbers. We examined these data to determine
whether the dissemination of published CUAs followed pat-
terns identified for other innovations and what patterns in
clinical areas or journal types existed over time.
RESULTS
Over the study period, a total of 539 studies were identified
and included. The number of cost-utility analyses published
on an annual basis rose steadily between 1976 and 1999 and
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Figure 1. Dissemination curve for cost-utility analyses (CUA) publications.
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Figure 2. Changes in percentage of articles published in
each journal type over time. HSR, health services research;
GENMED, general medicine; MEDSPEC, clinical specialty.
then leveled out at approximately 85 publications per year.
When the average number of publications is plotted against
3-year periods (Figure 1), the plot reveals an S-shaped curve
that parallels curves seen throughout the literature on the
diffusion of innovations (6).
The 539 studies appeared in a total of 204 different
journals and covered many clinical areas, particularly car-
diology, oncology, and pharmacology. The journals them-
selves included general medical, health services research,
and clinical specialties, including pharmacology and nurs-
ing. Figure 2 shows the percentage of articles appearing in
each journal type over time. It appears that, whereas CUAs
were initially published more frequently in general medical
or health services research journals, there was a clear increase
in the diffusion of CUA into subspecialty journals over time.
Table 1 shows dates of first publication of identified CUAs
in specific specialties as well as the pattern of publication
in that specialty area over time. The concentration ratio for
research centers as measured by the HHI decreased over time
(Figure 3).
CONCLUSIONS
The spread of CUA through the medical literature follows
patterns identified for the diffusion of other new technolo-
gies and processes. Diffusion processes are dependent on per-
ceptions of innovations, characteristics of potential adopters
and contextual factors. In the case of CUA, changing health-
care environments leading to improved need for and per-
ception of cost-based studies and the wider training of clin-
icians and researchers in CUA methodology are likely to
have interacted to lead to the diffusion patterns seen in this
work.
Early adopters of the CUA innovation were affiliated
with very few research institutes, but the concentration ratio
has decreased as the innovation has spread to additional cen-
ters. As with other new methods and innovations, the next
question to answer is what impact this spread has had on the
practice of medicine and formulation of health policy.
Table 1. Dates of First Publication of CUAs in Various Specialty Areas and Patterns of
Publication in Specialty Journals over Time
Specialty First CUA 1976–1990 1991–1996 1997–2002
Anesthesia 1995 0 1 0
Cardiology 1991 0 8 15
Critical Care 1996 0 1 4
Dermatology 1998 0 0 2
Endocrinology 1994 0 1 5
Gastroenterology 1991 0 8 15
General Medicine 1977 23 33 87
Hematology 1982 1 7 13
Infectious Disease 1991 0 1 20
Mental Health 1994 0 2 6
Neurology 1997 0 0 8
Non-clinical/methods 1976 5 19 28
Nursing 1995 0 1 1
Oncology 1988 2 10 29
Ophthalmology 2000 0 0 5
Otolaryngology 1995 0 2 2
Pathology 1985 1 0 1
Pediatric Medicine 1993 0 2 5
Pharmacology 1994 0 8 30
Pulmonary 1994 0 4 8
Radiology 1990 1 6 20
Rheumatology 1994 0 4 8
Surgery 1993 3 26 22
Urology 1995 0 2 3
Women’s medicine 2001 0 0 4
CUA, cost-utility analysis.
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Figure 3. Change in Herfindhal–Hirschman Index (HHI) over time.
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